MedTrace Logo

Users Study Of The Caverject Delivery System

NCT01747928 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2014-05-02

Study results available
· View outcomes & findings →

Summary

Usability testing of the dual-chambered syringe in conjunction with the proposed patient instructions for use.

Conditions

  • Healthy

Interventions

OTHER

dual-chamber syringe

dual-chamber syringe for mock injection

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01747928 on ClinicalTrials.gov